1. < Home

Scleroderma

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression

Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M, Hoffmann-Vold AM, Kuwana M, Stock C, Alves M, Sambevski S, Denton ...

By sjmartinez • February 17, 2023
Predicting the Progression of Very Early Systemic Sclerosis: Current Insights

Bellocchi C, Chung A, Volkmann ER. Predicting the Progression of Very Early Systemic Sclerosis: Current Insights. Open Access Rheumatol. 2022 Sep 15;14:171-186. doi: 10.2147/OARRR.S285409. PMID: ...

By sjmartinez • September 15, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort

Bae SS, Pourzand L, Hyun Kim G, Villegas BE, Oh A, Furst DE, Goldin J, Tashkin DP. The disconnect between visual assessment of air trapping ...

By rosaguerrero • May 20, 2022